P

PredictImmune

13 employees

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Basic info

Industry

hospitals and health care

Sectors

Medical Device
Biotechnology
Crohn's
IBD
prognosis
inflammatory bowel disease
Health Care
immune-mediated diseases
Medical
ulcerative colitis
Biopharma
Life Science

Date founded

2017

Funding rounds raised

Total raised

$12M

from 10 investors over 10 rounds

P

PredictImmune raised undisclosed on March 20, 2023

Investors: Crohn's & Colitis Foundation of America

P

PredictImmune raised $7.1M on May 12, 2021

Investors: Parkwalk Advisors

P

PredictImmune raised $12M on July 30, 2019

Investors: Cambridge Enterprise, Cambridge Innovation Capital plc and Parkwalk Advisors

P

PredictImmune raised $127K on December 13, 2018

Investors: Innovate UK

P

PredictImmune raised $5.9M on April 30, 2018

Investors: Wellcome Trust

P

PredictImmune raised $6.1M on May 8, 2017

Investors: Cambridge Enterprise, Wren Capital LLP and Parkwalk Advisors

FAQ